GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Short-Term Capital Lease Obligation

ABL Bio (XKRX:298380) Short-Term Capital Lease Obligation : ₩531 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Short-Term Capital Lease Obligation?

ABL Bio's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩531 Mil.

ABL Bio's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (₩1,015 Mil) to Dec. 2023 (₩784 Mil) and declined from Dec. 2023 (₩784 Mil) to Mar. 2024 (₩531 Mil).

ABL Bio's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩502 Mil) to Dec. 2022 (₩1,167 Mil) but then declined from Dec. 2022 (₩1,167 Mil) to Dec. 2023 (₩784 Mil).

ABL Bio Short-Term Capital Lease Obligation Historical Data

The historical data trend for ABL Bio's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Short-Term Capital Lease Obligation Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial 801.39 940.31 502.03 1,166.86 784.47

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,127.22 1,060.60 1,015.31 784.47 531.25

ABL Bio Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

ABL Bio Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ABL Bio's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:064550 XKRX:016790 XKRX:085660 XKRX:096530 XKRX:005250 XKRX:950160 XKRX:950210 XKRX:087010 XKRX:141080 XKRX:310210 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Website
https://www.ablbio.com
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines